Literature DB >> 14623493

Phosphorus magnetic resonance spectroscopy: its utility in examining the membrane hypothesis of schizophrenia.

Ravinder Reddy1, Matcheri S Keshavan.   

Abstract

A novel approach to understanding the pathophysiology of schizophrenia has been the investigation of membrane composition and functional perturbations, referred to as the "Membrane Hypothesis of Schizophrenia." The evidence in support of this hypothesis has been accumulating in findings in patients with schizophrenia of reductions in phospholipids and essential fatty acids various peripheral tissues. Postmortem studies indicate similar reductions in essential fatty acids in the brain. However, the use of magnetic resonance spectroscopy (MRS) has provided an opportunity to examine aspects of membrane biochemistry in vivo in the living brain. MRS is a powerful, albeit complex, noninvasive quantitative imaging tool that offers several advantages over other methods of in vivo biochemical investigations. It has been used extensively in investigating brain biochemistry in schizophrenia. Phosphorus MRS (31P MRS) can provide important information about neuronal membranes, such as levels of phosphomonoesters that reflect the building blocks of neuronal membranes and phosphodiesters that reflect breakdown products. 31P MRS can also provide information about bioenergetics. Studies in patients with chronic schizophrenia as well as at first episode prior to treatment show a variety of alterations in neuronal membrane biochemistry, supportive of the membrane hypothesis of schizophrenia. Below, we will briefly review the principles underlying 31P MRS and findings to date. Magnetic resonance spectroscopy (MRS) is a powerful, albeit complex, imaging tool that permits investigation of brain biochemistry in vivo. It utilizes the magnetic resonance imaging hardware. It offers several advantages over other methods of in vivo biochemical investigations. MRS is noninvasive, there is no radiation exposure, does not require the use of tracer ligands or contrast media. Because of it is relatively benign, repeated measures are possible. It has been used extensively in investigating brain biochemistry in schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14623493     DOI: 10.1016/j.plefa.2003.08.011

Source DB:  PubMed          Journal:  Prostaglandins Leukot Essent Fatty Acids        ISSN: 0952-3278            Impact factor:   4.006


  13 in total

Review 1.  Schizophrenia, "Just the Facts" 6. Moving ahead with the schizophrenia concept: from the elephant to the mouse.

Authors:  Matcheri S Keshavan; Henry A Nasrallah; Rajiv Tandon
Journal:  Schizophr Res       Date:  2011-02-12       Impact factor: 4.939

2.  Phospholipid profile in the postmortem hippocampus of patients with schizophrenia and bipolar disorder: no changes in docosahexaenoic acid species.

Authors:  Kei Hamazaki; Kwang H Choi; Hee-Yong Kim
Journal:  J Psychiatr Res       Date:  2010-01-06       Impact factor: 4.791

Review 3.  The Utility of Magnetic Resonance Spectroscopy for Understanding Substance Use Disorders: A Systematic Review of the Literature.

Authors:  Tracy Hellem; Xianfeng Shi; Gwen Latendresse; Perry F Renshaw
Journal:  J Am Psychiatr Nurses Assoc       Date:  2015 Jul-Aug       Impact factor: 2.385

4.  The interplay between mitochondrial complex I, dopamine and Sp1 in schizophrenia.

Authors:  Dorit Ben-Shachar
Journal:  J Neural Transm (Vienna)       Date:  2009-11       Impact factor: 3.575

Review 5.  Disturbed structural connectivity in schizophrenia primary factor in pathology or epiphenomenon?

Authors:  Andreas Konrad; Georg Winterer
Journal:  Schizophr Bull       Date:  2007-05-07       Impact factor: 9.306

6.  Phospholipid composition of postmortem schizophrenic brain by 31P NMR spectroscopy.

Authors:  John M Pearce; Richard A Komoroski; Robert E Mrak
Journal:  Magn Reson Med       Date:  2009-01       Impact factor: 4.668

Review 7.  Neuroimaging in Schizophrenia.

Authors:  Matcheri S Keshavan; Guusje Collin; Synthia Guimond; Sinead Kelly; Konasale M Prasad; Paulo Lizano
Journal:  Neuroimaging Clin N Am       Date:  2019-11-11       Impact factor: 2.264

Review 8.  Neurobiological markers of illness onset in psychosis and schizophrenia: The search for a moving target.

Authors:  Christos Pantelis; Murat Yücel; Emre Bora; Alex Fornito; Renée Testa; Warrick J Brewer; Dennis Velakoulis; Stephen J Wood
Journal:  Neuropsychol Rev       Date:  2009-09       Impact factor: 7.444

9.  Ultrastructural alterations of myelinated fibers and oligodendrocytes in the prefrontal cortex in schizophrenia: a postmortem morphometric study.

Authors:  Natalya A Uranova; Olga V Vikhreva; Valentina I Rachmanova; Diana D Orlovskaya
Journal:  Schizophr Res Treatment       Date:  2011-06-28

10.  Gray matter volumetric abnormalities associated with the onset of psychosis.

Authors:  Wi Hoon Jung; Stefan Borgwardt; Paolo Fusar-Poli; Jun Soo Kwon
Journal:  Front Psychiatry       Date:  2012-12-03       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.